Back

Network nature of ligand-receptor interactions underlies disease comorbidity in the brain

Grant-Peters, M.; Fairbrother-Browne, A.; Hicks, A.; Guo, B.; Reynolds, R. H.; Huuki-Myers, L. A.; Eagles, N.; Brenton, J.; Garcia-Ruiz, S.; Wood, N.; Gandhi, S.; Martinowich, K.; Maynard, K.; Collado-Torres, L.; Ryten, M.

2024-06-16 neuroscience
10.1101/2024.06.15.599140 bioRxiv
Show abstract

Neurodegenerative disorders have overlapping symptoms and have high comorbidity rates, but this is not reflected in overlaps of risk genes. We have investigated whether ligand-receptor interactions (LRIs) are a mechanism by which distinct genes associated with disease risk can impact overlapping outcomes. We found that LRIs are likely disrupted in neurological disease and that the ligand-receptor networks associated with neurological diseases have substantial overlaps. Specifically, 96.8% of LRIs associated with disease risk are interconnected in a single LR network. These ligands and receptors are enriched for roles in inflammatory pathways and highlight the role of glia in cross-disease risk. Disruption to this LR network due to disease-associated processes (e.g. differential transcript use, protein misfolding) is likely to contribute to disease progression and risk of comorbidity. Our findings have implications for drug development, as they highlight the potential benefits and risks of pursuing cross-disease drug targets.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.